Piedmont Chemical: Difference between revisions
Mythopoeia (talk | contribs) mNo edit summary |
Mythopoeia (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
{{Infobox company | {{Infobox company | ||
| name = Piedmont Chemical | | name = Piedmont Chemical | ||
| logo = [[File:Peidmont Chemical.svg|150px]] | | logo = [[File:Peidmont Chemical.svg|150px]]<br />{{Center|Logo}}<br />[[File:BofA_Corp_Center.jpg|250px]]{{Center|Headquarters}} | ||
| type = {{wp|Public company|Public}} | | type = {{wp|Public company|Public}} | ||
| traded_as = PPST:PC | | traded_as = PPST:PC | ||
Revision as of 17:04, 4 July 2022
 Logo  Headquarters | |
| Public | |
| Traded as | PPST:PC |
| Industry | Pharmaceutical Chemical |
| Founder | Heiner Knoerr (1838–1911) Ian Uhlmann (1846–1906) |
Piedmont Chemical (Vespasian: Piemonte Chimica) formerly known as Standard Chemical (Vespasian: Chimico Standard) is an Adamantine multinational chemical and pharmaceutical corporation headquartered in Casamassella, San Loreto. The company was established in 1891 in Porto Pellegrini by two Weranian immigrants, Heiner Knoerr (1838–1911) and Ian Uhlmann (1846–1906). It has regional offices and production sites in Gaullica, Shangea and Marchenia.
Piedmont Chemical develops and produces an array of medicines, vaccines and industrial chemicals. Piedmont is best known for its development of Aspirina (acetylsalicylic acid) (1890), Insulina (insulin lispro) (1994) and Lucida (chlorpromazine) (1949). Piedmont's initial financial success was from its production of bleach and potassium bromide in the 1890s. During the Great War it mass produced key components for mustard gas, including potassium sulfide and 2-chloroethanol. In 1961 its brand of thalidomide was removed from shelves in Estmere for causing the malformation of infant limbs, although returning in 1998 as a prescription treatment for cancer. It was among the first companies to mass-produce the polio vaccine, and has been a leading developer and producer of antipsychotics, antidepressants and synthetic opioids. Piedmont has several medications that individually generate more than ADM$1 billion in annual revenues.
Piedmont is a component of the Piedmont Cato Industrial Average (PCIA) and is publicly traded on the Porto Pellegrini Stock Exchange (PPST) and several of its chemical commodities are sold on the Porto Pellegrini Board of Trade (PPBT). The company is the second largest corporation by operating income, and the first in revenue in Adamantina. In 2020, 18% of the company's revenues came from Adamantina, 15% from nations in Asteria Inferior, 26% from Asteria Superior and 41% from Coius and Euclea.